Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 50, 2020 - Issue 7
273
Views
10
CrossRef citations to date
0
Altmetric
ARTICLES

ZnO nanoparticles catalyzed synthesis of bis- and poly(imidazoles) as potential anticancer agents

, , &
Pages 980-996 | Received 17 Oct 2019, Published online: 19 Feb 2020
 

Abstract

A synthesis of bis- and poly(imidazoles) by one-pot three-component reaction of 1,2-diketone with aldehydes and ammonium acetate in the presence of catalytic amount of ZnO nanocatalyst is reported. The reactions were performed under conventional heating as well as under microwave irradiation. The anticancer activities of the synthesized compounds were evaluated against human breast adenocarcinoma cell line (MCF-7), liver cancer cell line (HepG-2), and epithelial colorectal adenocarcinoma cells (CaCO-2). The results of the cytotoxic activity revealed that compound 16 b with bis(imidazole) analog that incorporated a 4,5-difuran rings was potent against HepG-2 cancer cells (IC50 = 8.14 µM) with high selectivity index (SI = 27.47). Compound 25 incorporating four imidazole units was active against MCF-7 cell line (IC50 = 12.62 µM) and showed a significant selectivity index (SI = 7.71). Moreover, compound 27 containing six imidazole units exhibited the highest activity against the CaCO-2 cell line (IC50 = 32.51 μM) with SI = 4.09.

Graphical Abstract

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.